Abstract
Evidence is presented that cells transformed by adenovirus type 12 are oncogenic because they escape from T-cell immunity. This effect is brought about by reducing the expression of class I transplantation antigens and is a function of the protein translated from the 13S mRNA, transcribed from early region 1a. These findings establish a novel mechanism by which transformed cells can acquire an oncogenic phenotype.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Freeman, A. E., Black, P. H., Wolford, R. & Huebner, R. J. J. Virol. 1, 362–367 (1967).
Freeman, A. E. et al. Proc. natn. Acad. Sci. U.S.A. 58, 1205–1212 (1967).
McAllister, R. M., Nicholson, M. O., Lewis, A. M., MacPherson, I. & Huebner, R. J. J. gen. Virol. 4, 29–36 (1969).
Gallimore, P. H. J. gen. Virol. 16, 99–102 (1972).
Gallimore, P. H., McDougall, J. K. & Chen, L. B. Cell 10, 669–678 (1977).
Flint, S. J. in Molecular Biology of Tumor Viruses II: DNA Tumor Viruses 2nd edn (ed. Tooze, J.) 547–576 (Cold Spring Harbor Laboratory, New York, 1980).
Bernards, R., Houweling, A., Schrier, P. I., Bos, J. L. & Van der Eb, A. J. Virology 120, 422–432 (1982).
Bernards, R., Schrier, P. I., Bos, J. L. & Van der Eb, A. J. Virology 127, 45–54 (1983).
Schrier, P. I., Bernards, R., Vaessen, R. T. M. J., Houweling, A. & Van der Eb, A. J. Nature 305, 771–775 (1983).
Zinkernagel, R. M. & Dohenty, P. C. Adv. Immun. 27, 51–177 (1979).
Bevan, M. J. Proc. natn. Acad. Sci. U.S.A. 74, 2094–2098 (1977).
Nabholz, M. et al. Eur. J. Immun. 4, 378–387 (1974).
Melief, C. J. M. & Schwartz, R. S. in Cancer: a Comprehensive Treatise Vol. 1 (ed. Becker, F. F.) 121–159 (Plenum, New York, 1975).
Perricaudet, M., le Moullec, J., Tiollais, P. & Petterson, U. Nature 288, 174–176 (1980).
Bos, J. L. et al. Virology (in the press).
Stutman, C. Adv. Cancer Res. 22, 261–422 (1975).
Klein, G. Cancer 45, 2486–2499 (1980).
Shin, S., Freedman, V. H., Risser, R. & Pollack, R. Proc. natn. Acad. Sci. U.S.A. 72, 4435–4439 (1975).
Shin, S. Meth. Enzym. 58, 370–379 (1979).
Bos, J. L. & ten Wolde-Kraamwinkel, H. C. EMBO J. 2, 73–76 (1983).
Jones, N. & Shenk, T. Proc. natn. Acad. Sci. U.S.A. 76, 3665–3669 (1980).
Berk, A. J., Lee, F., Harrison, T., Williams, J. & Sharp, P. H. Cell 17, 935–944 (1979).
Nevins, J. R. Cell 26, 213–220 (1981).
Ricciardi, R. P., Jones, R. L., Cepko, C. L., Sharp, P. A. & Roberts, B. E. Proc. natn. Acad. Sci. U.S.A. 78, 6121–6125 (1981).
Nevins, J. R. Cell 29, 913–919 (1982).
Bos, J. L. et al. Cell 27, 121–131 (1981).
Melief, C. J. M., de Waal, L. P., Van der Meulen, M. Y., Melvold, R. W. & Kohn, H. I. J. exp. Med. 151, 993–1013 (1980).
Montell, C., Fisher, E. F., Caruthers, M. H. & Berk, A. J. Nature 295, 380–384 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bernards, R., Schrier, P., Houweling, A. et al. Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature 305, 776–779 (1983). https://doi.org/10.1038/305776a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/305776a0